190 related articles for article (PubMed ID: 21787286)
1. Potential anti-catabolic and anabolic properties of strontium ranelate.
Mentaverri R; Brazier M; Kamel S; Fardellone P
Curr Mol Pharmacol; 2012 Jun; 5(2):189-94. PubMed ID: 21787286
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate improves bone microarchitecture in osteoporosis.
Hamdy NA
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
[TBL] [Abstract][Full Text] [Related]
3. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
Shiraki M
Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
[No Abstract] [Full Text] [Related]
4. The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial.
Quesada-Gómez JM; Muschitz C; Gómez-Reino J; Greisen H; Andersen HS; Dimai HP
Osteoporos Int; 2011 Sep; 22(9):2529-37. PubMed ID: 21052638
[TBL] [Abstract][Full Text] [Related]
5. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
Gallacher SJ; Dixon T
Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
[TBL] [Abstract][Full Text] [Related]
6. Strontium ranelate: a look back at its use for osteoporosis.
Reginster JY; Neuprez A
Expert Opin Pharmacother; 2010 Dec; 11(17):2915-27. PubMed ID: 21050035
[TBL] [Abstract][Full Text] [Related]
7. How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis.
Marie PJ; Felsenberg D; Brandi ML
Osteoporos Int; 2011 Jun; 22(6):1659-67. PubMed ID: 20812008
[TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate in osteoporosis and beyond: identifying molecular targets in bone cell biology.
Marie PJ
Mol Interv; 2010 Oct; 10(5):305-12. PubMed ID: 21045244
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.
Rolland Y; Abellan Van Kan G; Gillette-Guyonnet S; Roux C; Boonen S; Vellas B
Bone; 2011 Feb; 48(2):332-8. PubMed ID: 20817053
[TBL] [Abstract][Full Text] [Related]
10. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Tat SK; Pelletier JP; Mineau F; Caron J; Martel-Pelletier J
Bone; 2011 Sep; 49(3):559-67. PubMed ID: 21700005
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of strontium ranelate treatment on BMD.
Blake GM; Fogelman I
J Bone Miner Res; 2005 Nov; 20(11):1901-4. PubMed ID: 16234961
[No Abstract] [Full Text] [Related]
12. [Strontium ranelate for osteoporosis treatment].
Kurth A
Orthopade; 2014 Feb; 43(2):181. PubMed ID: 24693555
[No Abstract] [Full Text] [Related]
13. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
Marie PJ
Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
[TBL] [Abstract][Full Text] [Related]
14. Anabolic skeletal therapy for osteoporosis.
Girotra M; Rubin MR; Bilezikian JP
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
[TBL] [Abstract][Full Text] [Related]
15. The action of Strontium ranelate: myth or reality.
Bunyaratavej N
J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S35-7. PubMed ID: 22338924
[TBL] [Abstract][Full Text] [Related]
16. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
Adami S
Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
[TBL] [Abstract][Full Text] [Related]
17. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
Middleton ET; Steel SA; Aye M; Doherty SM
J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000
[TBL] [Abstract][Full Text] [Related]
18. Strontium ranelate: a physiological approach for an improved bone quality.
Ammann P
Bone; 2006 Feb; 38(2 Suppl 1):15-8. PubMed ID: 16455318
[TBL] [Abstract][Full Text] [Related]
19. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
Kaliterna DM
Reumatizam; 2008; 55(2):73-4. PubMed ID: 19024281
[TBL] [Abstract][Full Text] [Related]
20. Improvement in bone strength parameters. The role of strontium ranelate.
Tournis S
J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]